Moderna has enrolled and dosed its first participant in a phase 2 trial testing a COVID-19 booster shot that targets omicron, the drugmaker said Jan. 26.
Read the full post on Becker's Hospital Review - Healthcare News
Moderna launches omicron-specific booster trial
